← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
MF Analyser

Mahindra Manulife Balanced Advantage Fund

Regular Plan · IDCW · Balanced Advantage · Scheme code 149405

NAV₹11.6543as on 25 Sep 2026
Fund houseMahindra Manulife Mutual Fund
CategoryBalanced Advantage
Plan & optionRegular · IDCW
History4.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme -2.470.665.13 -5.230.58— ——3.26
Nifty 100
benchmark		 0.253.49-1.52 1.8410.529.38 ——12.79
Balanced Advantage
category median		 ——— 0.658.127.17 —7.94—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 11.3% -0.52 -0.64 0.63 -4.17% -20.9% 58.10
Nifty 100
benchmark		 17.1%0.23 0.32—— -37.0%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 55 months this scheme and its benchmark share.

Growth of ₹100 since launch

9010512113720242026MF Analyser

Drawdown from peak (%)

0%-8%-16%-23%20242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
182 -9.2% 1.4% 32.0% 46%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
56% 62% 0.76 9.2% -0.57 -3.79

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 55 months this scheme and Nifty 100 share.

MF Analyser

Mahindra Manulife Balanced Advantage Fund

Regular Plan · IDCW

Allocation

By asset

Equity69.76%
Debt21.90%
Cash & Equivalents5.79%
REITs / InvITs3.71%

By market cap

Concentration

Number of stocks82
Top 5 stocks14.05%
Top 10 stocks25.01%
Top 20 stocks41.92%
Lines in the filing86
Largest holding4.06%
Largest sectorBanks 16.89%
Effective stocks67.7
Sectors held34
Cash5.79%

Effective stocks is what the concentration works out to: a fund holding 82 names but most of its money in a few behaves like a fund of 68. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Banks — 16.9%CRISIL AAA — 9.0%Pharmaceuticals & Biotechnology — 7.3%Cash & Equivalents — 5.8%CRISIL AA+ — 5.4%SOVEREIGN — 5.4%Retailing — 4.5%Finance — 3.9%IT - Software — 3.4%Other — 39.6%Banks16.9%CRISIL AAA9.0%Pharmaceuticals & Biotech…7.3%Cash & Equivalents5.8%CRISIL AA+5.4%SOVEREIGN5.4%Retailing4.5%Finance3.9%IT - Software3.4%Other39.6%
Banks16.89%
CRISIL AAA8.96%
Pharmaceuticals & Biotechnology7.34%
Cash & Equivalents5.79%
CRISIL AA+5.40%
SOVEREIGN5.37%
Retailing4.49%
Finance3.87%
IT - Software3.44%
Realty3.33%
Automobiles3.32%
Healthcare Services3.06%
Telecom - Services3.02%
Capital Markets2.71%
Petroleum Products2.28%
Aerospace & Defense2.04%
Ferrous Metals1.81%
Transport Services1.68%
ICRA AA+1.63%
Consumer Durables1.46%
MF Analyser

Mahindra Manulife Balanced Advantage Fund

Regular Plan · IDCW · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 ICICI Bank Limited Banks 257,500 37 4.06%
2 Triparty Repo Unclassified — 32 3.46%
3 8.52% Muthoot Finance Limited 2028 CRISIL AA+ 2,500,000 25 2.70%
4 7.44% National Bank For Agriculture and Rural Development 2029 CRISIL AAA 2,500,000 25 2.69%
5 Bharti Airtel Limited Telecom - Services 118,000 21 2.32%
6 Reliance Industries Limited Petroleum Products 165,000 21 2.28%
7 IndusInd Bank Limited Banks 206,000 21 2.27%
8 HDFC Bank Limited Banks 291,201 21 2.24%
9 7.71% Government of India 2066 SOVEREIGN 2,000,000 20 2.19%
10 Eternal Limited Retailing 605,000 20 2.15%
11 Axis Bank Limited Banks 150,000 20 2.11%
12 Brookfield India Real Estate Trust Realty 566,396 19 2.10%
13 Laurus Labs Limited Pharmaceuticals & Biotechnology 93,261 18 1.93%
14 Jindal Steel Limited Ferrous Metals 139,812 17 1.81%
15 Apollo Hospitals Enterprise Limited Healthcare Services 18,500 16 1.78%
16 8.30% Godrej Properties Limited 2027 ICRA AA+ 1,500,000 15 1.63%
17 The Federal Bank Limited Banks 420,000 15 1.62%
18 7.70% Power Finance Corporation Limited 2026 CRISIL AAA 1,450,000 15 1.57%
19 State Bank of India Banks 131,500 14 1.51%
20 Bajaj Finance Ltd Finance 129,549 14 1.48%
21 Tech Mahindra Limited IT - Software 84,000 14 1.48%
22 Titan Company Limited Consumer Durables 26,500 14 1.46%
23 Mahindra & Mahindra Limited Automobiles 39,600 13 1.41%
24 Senores Pharmaceuticals Limited Pharmaceuticals & Biotechnology 90,000 13 1.40%
25 Larsen & Toubro Limited Construction 31,400 13 1.38%
26 Aditya Vision Ltd Retailing 206,658 12 1.34%
27 Bharat Heavy Electricals Limited Electrical Equipment 278,000 12 1.33%
28 Bharat Electronics Limited Aerospace & Defense 288,000 12 1.29%
29 Glenmark Pharmaceuticals Limited Pharmaceuticals & Biotechnology 48,065 12 1.29%
30 Fortis Healthcare Limited Healthcare Services 130,000 12 1.28%
MF Analyser

Mahindra Manulife Balanced Advantage Fund

Regular Plan · IDCW · where the money sits

What the manager did last month

Between the filings of 31 Jul 2026 and 31 Aug 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹8 cr ₹2 cr 1 2 +2.21%
StockShares tradedShares PriceValue
₹ cr
New position
Acutaas Chemicals Limited 16,472 entered — 5.2
Added to
Bajaj Finance Ltd 30,000 +30.1% -7.4% 3.2
Hindustan Aeronautics Limited 6,500 +81.3% +3.3% 3.1
Coforge Limited 8,500 +22.4% +15.4% 1.7
Trimmed
Bharat Heavy Electricals Limited 32,000 -10.3% +8.8% 1.4
Laurus Labs Limited 3,739 -3.9% +5.4% 0.7
Sold out of
Power Grid Corporation of India Limited 290,000 exited — 8.2
SRF Limited 26,000 exited — 6.8
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr
Debt: bills, CDs and commercial paper ₹186 cr ₹202 cr +₹16 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 28 Sep 2026.